Prevention/Epidemiology

Australia: Starpharma Signs Agreement With Condom Maker

From CDC National Prevention Information Network

July 19, 2007

Starpharma Holdings Ltd. has signed an agreement with a leading condom maker for use of its VivaGel as a condom coating. The agreement includes a program of evaluation and development and commercialization rights in a developed world market. For reasons of confidentiality, the condom company's name cannot be disclosed but it holds a leading market position within that region.

Back to other news for July 2007

Adapted from:
Australian Associated Press
07.18.2007

House Votes to Remove Amendment From Labor-HHS Appropriations Bill That Would Have Reduced Ryan White Funding in Some Areas

New Jersey: Magic Says Blacks Should Team Up to Conquer AIDS

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

More HIV News

What Will HIV Treatment Look Like in 5 Years?

2014 HIV/Hepatitis C Coinfection Update

What Major HIV Research Developments Does 2014 Hold in Store?

5 Years After My HIV Diagnosis

One-a-Day HIV Treatments: How Do They Compare? (Infographic)

More >>

TheBody.com App

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

U.S. ASO Finder

The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.